𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reduced-Dose Tacrolimus with Mycophenolate Mofetil vs. Standard-Dose Tacrolimus in Liver Transplantation: A Randomized Study

✍ Scribed by K. Boudjema; C. Camus; F. Saliba; Y. Calmus; E. Salamé; G. Pageaux; C. Ducerf; C. Duvoux; C. Mouchel; A. Renault; P. Compagnon; R. Lorho; E. Bellissant

Book ID
114805941
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
311 KB
Volume
11
Category
Article
ISSN
1600-6135

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics, efficacy, and safety o
Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients
✍ Björn Nashan; Faouzi Saliba; Francois Durand; Rafael Barcéna; Jose Ignacio Herre 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB 👁 1 views

The pharmacokinetics of mycophenolate mofetil (MMF) in liver transplant recipients may change because of pharmacokinetic interactions with coadministered immunosuppressants or because changes in the enterohepatic anatomy may affect biotransformation of MMF to mycophenolic acid (MPA) and enterohepati

Evaluation of renal function in liver tr
Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial
✍ Eric M. Yoshida; Paul J. Marotta; Paul D. Greig; Norman M. Kneteman; Denis Marle 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Posttransplant chronic renal failure, secondary to calcineurin inhibitor agents, is emerging as a major problem in liver transplantation. We report a randomized clinical trial comparing daclizumab, delayed low-dose tacrolimus (target trough level 4-8 ng/mL, starting day 4-6), Investigational Arm (n

A prospective randomized open study in l
A prospective randomized open study in liver transplant recipients: Daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids
✍ Alejandra Otero; Evaristo Varo; Jorge Ortiz de Urbina; Rafael Martín-Vivaldi; Va 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB

This open-label, randomized study compared the efficacy of a regimen of corticosteroids and tacrolimus (standard therapy group, n ϭ 79) with a regimen of daclizumab induction therapy in combination with mycophenolate mofetil and tacrolimus (modified therapy group, n ϭ 78) in primary liver transplant